Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Rating of “Moderate Buy” from Brokerages

Posted by on Jun 7th, 2023

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two ratings firms that are currently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $303.35.

A number of research firms have commented on ISRG. Truist Financial boosted their price target on shares of Intuitive Surgical from $325.00 to $347.00 in a research report on Thursday, May 18th. StockNews.com initiated coverage on shares of Intuitive Surgical in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Sanford C. Bernstein lifted their price objective on shares of Intuitive Surgical from $350.00 to $365.00 in a research note on Wednesday, May 31st. Bank of America lifted their price objective on shares of Intuitive Surgical from $300.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, April 19th. Finally, Citigroup lifted their price objective on shares of Intuitive Surgical from $305.00 to $317.00 and gave the stock a “buy” rating in a research note on Wednesday, April 19th.

Intuitive Surgical Stock Down 0.6 %

Shares of NASDAQ:ISRG opened at $315.72 on Wednesday. The company has a market cap of $110.63 billion, a PE ratio of 86.26, a P/E/G ratio of 5.58 and a beta of 1.31. The company’s 50-day moving average price is $291.29 and its 200 day moving average price is $266.56. Intuitive Surgical has a fifty-two week low of $180.07 and a fifty-two week high of $318.92.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its quarterly earnings results on Tuesday, April 18th. The medical equipment provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. Intuitive Surgical had a net margin of 20.40% and a return on equity of 11.39%. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm earned $1.00 EPS. Intuitive Surgical’s revenue was up 14.3% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical will post 4.3 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Mark J. Rubash sold 7,323 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 28th. The shares were sold at an average price of $300.00, for a total value of $2,196,900.00. Following the completion of the sale, the director now directly owns 15,482 shares in the company, valued at $4,644,600. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Mark J. Rubash sold 7,323 shares of the business’s stock in a transaction on Friday, April 28th. The shares were sold at an average price of $300.00, for a total value of $2,196,900.00. Following the completion of the sale, the director now directly owns 15,482 shares in the company, valued at $4,644,600. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP David J. Rosa sold 40,764 shares of the business’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $299.20, for a total transaction of $12,196,588.80. Following the completion of the sale, the executive vice president now owns 155,712 shares of the company’s stock, valued at $46,589,030.40. The disclosure for this sale can be found here. Insiders sold 60,023 shares of company stock worth $17,967,137 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the company. HHM Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 1,314.3% in the first quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 92 shares during the last quarter. MADDEN SECURITIES Corp acquired a new position in Intuitive Surgical during the 4th quarter valued at $26,000. Paragon Wealth Strategies LLC acquired a new position in Intuitive Surgical during the 4th quarter valued at $27,000. Bogart Wealth LLC raised its stake in Intuitive Surgical by 721.4% during the 1st quarter. Bogart Wealth LLC now owns 115 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 101 shares during the last quarter. Finally, Barrett & Company Inc. acquired a new position in Intuitive Surgical during the 1st quarter valued at $30,000. 81.96% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.

Featured Stories

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.